Walgreens Boots Alliance Inc (WBA) Shares Sold by Rhumbline Advisers

Rhumbline Advisers lessened its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,494,425 shares of the pharmacy operator’s stock after selling 24,796 shares during the period. Rhumbline Advisers owned approximately 0.16% of Walgreens Boots Alliance worth $108,944,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the business. BlackRock Inc. boosted its holdings in shares of Walgreens Boots Alliance by 1.5% in the 2nd quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock valued at $3,189,715,000 after acquiring an additional 771,307 shares during the last quarter. LSV Asset Management boosted its holdings in shares of Walgreens Boots Alliance by 28.5% in the 3rd quarter. LSV Asset Management now owns 11,183,914 shares of the pharmacy operator’s stock valued at $815,307,000 after acquiring an additional 2,479,681 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Walgreens Boots Alliance by 11.5% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock valued at $666,804,000 after acquiring an additional 1,143,819 shares during the last quarter. Northern Trust Corp boosted its holdings in shares of Walgreens Boots Alliance by 1.9% in the 2nd quarter. Northern Trust Corp now owns 11,102,159 shares of the pharmacy operator’s stock valued at $666,296,000 after acquiring an additional 208,235 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Walgreens Boots Alliance by 3.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 10,875,615 shares of the pharmacy operator’s stock valued at $652,699,000 after acquiring an additional 320,484 shares during the last quarter. 64.58% of the stock is currently owned by institutional investors.

Shares of NASDAQ WBA opened at $81.92 on Wednesday. Walgreens Boots Alliance Inc has a 1 year low of $59.07 and a 1 year high of $83.00. The firm has a market cap of $77.65 billion, a P/E ratio of 13.61, a PEG ratio of 1.30 and a beta of 0.74. The company has a current ratio of 0.82, a quick ratio of 0.38 and a debt-to-equity ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The firm had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. On average, research analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.

Several analysts have recently commented on WBA shares. TheStreet raised shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a report on Wednesday, September 12th. BidaskClub raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a report on Wednesday, September 12th. Loop Capital upped their price objective on shares of Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a report on Friday, October 12th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a report on Tuesday, September 25th. Finally, Barclays increased their price target on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a report on Friday, October 12th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $78.22.

In other Walgreens Boots Alliance news, SVP Kimberly R. Scardino sold 11,970 shares of the company’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.79, for a total transaction of $955,086.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the company’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the transaction, the executive vice president now owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The disclosure for this sale can be found here. Insiders have sold 66,706 shares of company stock valued at $5,268,584 over the last 90 days. 14.80% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2018/11/14/walgreens-boots-alliance-inc-wba-shares-sold-by-rhumbline-advisers.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Recommended Story: Balanced Fund

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply